Combination of growth pattern and tumor regression identifies a high-risk group in neoadjuvant treated rectal cancer patients-Reference-Cited by-同舟云学术

Combination of growth pattern and tumor regression identifies a high-risk group in neoadjuvant treated rectal cancer patients

Published:2017-05 Issue:5 Volume:18 Page:283-291
ISSN:1751-2972
Container-title:Journal of Digestive Diseases
language:en
Short-container-title:Journal of Digestive Diseases

Author:

Jessberger Jonas¹,Erlenbach-Wünsch Katharina²,Posselt Rebecca¹,Haderlein Marlen¹,Agaimy Abbas²,Fietkau Rainer¹,Hartmann Arndt²,Distel Luitpold¹^ORCID

Affiliation:

1. Department of Radiation Oncology; University Hospital of Erlangen, Friedrich-Alexander University of Erlangen-Nürnberg; Erlangen Germany

2. Institute of Pathology of the Universitätsklinikum Erlangen; Friedrich-Alexander University of Erlangen-Nürnberg; Erlangen Germany

Publisher

Wiley

Subject

Gastroenterology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1751-2980.12471/fullpdf

Reference18 articles.

1. Generation of epithelial cell polarity: roles for protein trafficking, membrane-cytoskeleton, and E-cadherin-mediated cell adhesion;Mays;Cold Spring Harb Symp Quant Biol,1995

2. Correlation between E-cadherin abnormal expressions in different types of cancer and the process of metastasis;Mărgineanu;Rev Med Chir Soc Med Nat Iasi,2008

3. E-cadherin and gastric cancer: cause, consequence, and applications;Liu;Biomed Res Int,2014

4. Novel findings about management of gastric cancer: a summary from 10th IGCC;Penon;World J Gastroenterol,2014

5. Preoperative versus postoperative chemoradiotherapy for rectal cancer;Sauer;N Engl J Med,2004

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor budding outperforms ypT and ypN classification in predicting outcome of rectal cancer after neoadjuvant chemoradiotherapy;BMC Cancer;2019-11-01

2. The potential predictive value of tumor budding for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer;Strahlentherapie und Onkologie;2018-08-01